Joseph Frank Oldakowski, Chief Accounting Officer of Clover Health Investments, Corp. /DE (NASDAQ:CLOV), filed a Form 4 on November 6, 2026, disclosing the acquisition of 186,403 shares of Class A common stock through a restricted stock unit award dated November 4, 2026.
Key Highlights
- Reporting person: Joseph Frank Oldakowski, Chief Accounting Officer of Clover Health Investments, Corp. /DE
- Transaction: Acquisition (Code A) of 186,403 shares of Class A common stock at $0, representing an RSU award
- Transaction date: November 4, 2026
- Post-transaction ownership: 462,300 shares of Class A common stock held directly
- Vesting schedule: 25% vests on November 4, 2027; remaining shares vest in 12 equal quarterly installments beginning three months after that date, with full vesting on November 4, 2030
- Filing signed: By Peter J. Rivas as attorney-in-fact for Joseph Frank Oldakowski on November 6, 2026
RSU Grant Details for Clover Health's Chief Accounting Officer
According to the filing, Clover Health Investments, Corp. /DE, the Medicare Advantage-focused health insurance company trading on NASDAQ:CLOV, granted its Chief Accounting Officer, Joseph Frank Oldakowski, a time-based restricted stock unit award covering 186,403 shares of Class A common stock. The transaction was recorded with a price of $0, consistent with the nature of an RSU award where no purchase price is paid at grant. Following the reported transaction, Oldakowski directly holds 462,300 shares of Class A common stock, as disclosed in the filing.
The filing describes a vesting schedule under which 25% of the RSUs will vest on the first anniversary of November 4, 2026, which is November 4, 2027. The remaining RSUs will vest in twelve equal quarterly installments beginning three months after that first anniversary date. According to the filing, this structure results in the RSUs being "fully vested on November 4, 2030," subject in each case to the continued service of Oldakowski on each applicable vesting date. The Form 4 was filed by one reporting person and was not marked as an amendment.
What Was Disclosed
Clover Health Investments, Corp. /DE disclosed that Chief Accounting Officer Joseph Frank Oldakowski received an RSU award of 186,403 Class A common shares on November 4, 2026, at no cost, bringing his direct beneficial ownership to 462,300 shares, with full vesting scheduled by November 4, 2030.



Please wait processing your request...